May 20 is Global Accessibility Awareness Day. Did you know that Breakthrough T1D’s website, jdrf.org, can be adjusted to better meet the needs of people living with disabilities?
Well, if you didn’t know… Now you do!
It’s all thanks to accessiBe, an Artificial Intelligence-enabled technology that removes common barriers that may otherwise prevent people with physical and psychiatric disabilities from accessing our website.
With just the touch of a button, visitors to our website can enable and customize the following accessibility profiles and adjust the settings to best meet their needs for an improved experience.
- Vision Impaired Profile—adjusts the website color scheme, as well as font size and color, so that it is accessible to the majority of visual impairments
- Seizure Safe Profile—enables people with epilepsy to use the website safely by eliminating the risk of seizures that result from flashing or blinking animations and risky color combinations
- Cognitive Disability Profile—provides various assistive features to help users with cognitive and learning disabilities focus on the essential elements of the website more easily
- ADHD Friendly Profile—significantly reduces distractions and noise, to help people with ADHD and neurodevelopmental disorders browse, read, and focus on the essential elements of the website more easily.
- Blind Users Profile (Screen-readers)—adjusts the website to be compatible with screen-readers
- Keyboard Navigation Profile (Motor)—enables motor-impaired persons to operate the website using the keyboard Tab, Shift+Tab, and the Enter keys.
To enable this functionality, users click on the gray Accessibility tab on the right side of our website, about halfway down the page.
Diversity and inclusion is a top priority for Breakthrough T1D. We continue to explore ways to create an environment where all of our staff, volunteers, and community members feel welcome, supported, and respected.
Learn more about Breakthrough T1D’s commitment to diversity and inclusion, and to improving health equity for members of the type 1 diabetes community.
